Indian brothers lose appeal over pharma award

The Singapore Court of Appeal has upheld a US$530 million ICC award that found Indian brothers Malvinder and Shivinder Mohan Singh liable for fraud over the sale of a pharmaceutical business.


Get unlimited access to all Global Arbitration Review content